TRPM7 expression levels are increased in nasopharyngeal carcinomas [46] and pancreatic ductal adenocarcinomas [47], and we showed in two independent cohorts that high TRPM7 expression associates with poor prognosis of breast cancer patients at time of diagnosis [34]. Here, TRPM7 is linked to breast cancer.